Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) with facilities in Belgium, Spain, the Netherlands, and Sweden, has completed its acquisition of Catalent’s drug product manufacturing facility in Somerset, New Jersey. This acquisition marks a significant milestone in Ardena’s strategic expansion into North America, strengthening its capabilities in late-stage and small-scale commercial manufac...